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Ionizing radiation (IR) is associated with thrombotic vascular occlusion predicting a
poor clinical outcome. Our study examined whether IR induced tissue factor (TF)
expression and procoagulability. We further investigated coordinated gene alterations
associated with TF upregulation in the myelomonocytic leukemia THP-1 cells.
Design and Methods
TF expression was determined by quantitative Reverse Transcriptase (TaqMan®) PCR,
TF ELISA and TF activity by a two stage chromogenic assay in the time course of days
1, 3, 7, 10, and 17 post IR. To detect IR-induced alterations in gene expression,
Affymetrix HG U133 Plus 2.0 microarrays were used.
Results
IR induced a significant increase in TF/GAPDH mRNA ratios and cellular TF protein on
days 3 and 7 post IR (20 Gy [p≤0.01] and 40 Gy [p≤0.01 vs. control]), suggesting a
late and persistent induction of TF. An increase in cellular TF activity was already
found 1 day post IR (20 Gy and 40 Gy [p≥0.001] vs. control respectively), suggesting
IR immediately alters the cellular thrombogenicity. TF upregulation post IR was con-
firmed in PBMNCs. Gene expression profiling showed IR increased the expression of
inflammatory and apoptosis-related pathways known to be involved in the regulation
of TF expression. 
Interpretation and Conclusions
TF upregulation together with inflammation and apoptosis may increase the thrombo-
genicity of tissues. The demonstrated upregulation of TF might play a pivotal role in
radiation associated thrombosis..
Key words: gene expression profiles, ionizing radiation, myelomonocytic cell line
THP-1, procoagulability, tissue factor.
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Ionizing radiation (IR) is associated with an increasedrisk of thrombotic occlusion of vessels and organfibrosis.1 Thrombotic events have been described as
a major complication after IR.2 Cells surviving acute
genotoxic stress post IR have been shown to display
delayed responses that can result in persistent effects
such as apoptosis and late thrombosis.3,4 Over-
expression and increased activity5 of tissue factor (TF)
have been shown to be involved in radiation-induced
changes.6 Furthermore, cultures of human arterial
endothelial cells expressed TF mRNA after irradiation in
combination with mechanical denudation.7
Alterations in transcriptional factor activity may con-
tribute to the increased thrombogenicity present post
IR.1 Sreekumar et al.8 found TF protein to be upregulat-
ed in response to radiation treatment as shown by
application of microarrays in LoVo colon carcinoma
cells. TF, the initiator of the extrinsic coagulation sys-
tem, induces thrombus formation by activation of
Factor VII resulting in activation of Factors IX and X. TF
is widely thought to play a leading role in thrombus for-
mation during thrombotic disorders.9-13 Besides its role
in hemostasis,13,14 upregulation of TF expression appears
to be characteristic of tumor tissue. There, TF is
expressed in malignant cells as well as in tumor-infil-
trating macrophages and endothelial cells.15,16,17 The pro-
coagulant activity of TF appears to play an important
role in the development of disseminated intravascular
disease (DIC).18 It has been shown that platelet activa-
tion and fibrin deposition is an essential part of TF-
dependent metastasis.19 In addition, blood clotting
abnormalities are detected in up to 90% of patients
with metastatic disease, and thrombosis represents the
most frequent cause of cancer mortality.20,21
Pathologic activation of the coagulation cascades by
aberrant expression of TF on the surface of monocytes
has been implicated in life-threatening thrombosis.22 TF
is expressed on the surface of human leukocytes and
leukemic myelomonocytic cells23,24 where it has been
reported to increase cellular thrombogenicity. In this
study, THP-1 cells were used as a model because of
their cytologic, histochemical, and functional properties
which resemble human monocytes.
In response to IR, monocytes have been reported to
produce inflammatory cytokines such as TNF-α. NFκB,
one of the main mediators of cellular responses
involved in inflammation, apoptosis and regulation of
TF expression, was documented to be activated by IR
through a cascade requiring endogenous TNF-α produc-
tion.25
The aim of our study was to clarify whether IR
induces the expression of procoagulant proteins such as
TF in the THP-1 model over a time period of 17 days. In
a second step, we examined coordinated gene alter-
ations associated with IR-induced thrombogenicity and
increased TF procoagulability on day 7 post IR. 
Design and Methods
Human myelomonocytic leukemia cell line 
The human monocytic cell line THP-1 has been pur-
chased from LGC Promochem (Wesel, Germany). Cells
were cultured in RPMI 1640 (GIBCO, Karlsruhe, Germany)
supplemented with 10% Fetal Calf Serum (FCS) (GIBCO,
Karlsruhe, Germany), 1mM L-glutamine (GIBCO,
Karlsruhe, Germany), and 1% penicillin/streptomycin
(GIBCO, Karlsruhe, Germany). They were tested and
found to be mycoplasma and endotoxin free. Cell viability
was assessed by trypan blue dye exclusion prior to all treat-
ments. 
Isolation of human peripheral blood mononuclear cells
(PBMNCs) and human PBMNC culture 
Human mononuclear cells were separated from blood
samples as follows: 18 mL of EDTA treated human periph-
eral blood was diluted (1:2) in warm (37°C) phosphate-
buffered saline (PBS, without Ca2+ and Mg2+ ) and purified
by the Ficoll-Paque Plus. Then 7 mL of Ficoll-Paque were
overlayed with 7 mL of the PBS-blood mixture and cen-
trifuged (610×g, 25 mins., room temperature, without
brake). The cell layer over the Ficoll-Paque was collected
and washed two times in 10 mL PBS and centrifuged
(610×g, 10 mins., room temperature). After the last wash,
the cell pellet was resuspended in 500 µL RPMI 1640 sup-
plemented with 10% Fetal Calf Serum (FCS), 1mM L-glut-
amine, and 1% penicillin/streptomycin. It was tested and
found to be mycoplasma and endotoxin free. Cell viability
was assessed by trypan blue dye exclusion prior to all treat-
ments. For downstream applications, cells were counted in
a hematocytometer (MICROS®60-OT System, Axonlab,
Stuttgart).
Irradiation of THP-1 cells 
THP-1 cells (106/mL) were irradiated with a single IR dose
of either 20 or 40 Gray. IR was generated by a linear accel-
erator (Varian Clinac 600 CD) with a maximum photon
energy of 6 MeV. Cell cultures were irradiated in a water-
equivalent-environment by a 25×25 cm3 photon field. With
this set-up, the dose homogeneity in the cell culture media
is in a range of 100-105%. Following irradiation, cells were
maintained in growth medium and afterwards subjected to
further analysis. To evaluate the effect of the NFκB-path-
way, inhibition experiments with BAY 11-7082 were per-
formed with 4×105 THP-1 cells/mL. These were incubated
1h pre IR and daily up to 3 days post IR with 5 µM BAY 11-
7082. Furthermore, THP-1 cells pre and post IR were sub-
jected to RNA extraction and QRTPCR analysis.
Tissue factor ELISA
To quantify the total TF protein content in irradiated and
control cells, THP-1 cells were subjected to ELISA accord-
ing to the manufacturer’s instructions (Imubind Tissue
Factor ELISA Kit, American Diagnostica, Pfungstadt,
Germany).
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Two stage chromogenic tissue factor activity assay
Measurement of TF activity was performed as previous-
ly described.14 Briefly, THP-1 cells were washed twice with
phosphate buffered saline (PBS), incubated in HEPES buffer
containing 0.1 M n-octyl-β-D-glycopyranosid. After addi-
tion of Factor VIIa, Factor X and Ca2+ TF-dependent Factor
Xa generation was measured at 405 nm using a chro-
mogenic substrate for Factor Xa. TF activity units were
assessed by a standard curve. The standard curve is con-
structed by plotting the mean slope absorbance value
measured for each lipidated TF standard against its corre-
sponding concentration [pg/mL] according to the manufac-
turer’s Actichrome® TF instruction sheet (American
Diagnostica, Pfungstadt, Germany). The activity (genera-
tion of Factor Xa) exhibited by 1 pg of lipidated TF corre-
sponds to 1 arbitrary TF-activity unit.
RNA extraction, reverse transcription
Total RNA of THP-1 cells or PBMNCs (106) was isolated
by RNeasy Mini Kit including Qiashredder columns
(Qiagen, Hilden, Germany). DNase I (Fermentas, St. Leon-
Rot, Germany) digested, reverse transcription of RNA was
performed with a First strand cDNA synthesis kit for RT-
PCR (AMV; Roche Applied Sciences) according to manu-
facturer’s instructions. 
Quantitative real-time PCR (QRTPCR)
PCR conditions for the TaqMan® (ABI Prism7000
Sequence Detection System, Applied Biosystems,
Darmstadt, Germany) are summarized in Table 1. Primers
and probes were purchased from TIB Molbiol (Berlin,
Germany). Data were analyzed using SDS 7000 software. 
GeneChip oligonucleotide microarrays target
preparation
GeneChips (HG U133 Plus 2.0) were purchased from
Affymetrix (Santa Clara, CA, USA). Target preparation and
microarray processing were carried out according to the
manufacturer’s recommendations. Briefly, 3 µg of total
RNA was used to prepare double-stranded cDNA.
Biotinylated cRNA was synthesized with an RNA tran-
script labeling kit and 20 µg of the cRNA product was
chemically fragmented to approximately 50-200
nucleotides. Quality of RNA was assessed using the
Agilent 2100 Bioanalyzer (Agilent Technologies GmbH,
Waldbronn, Germany). The target for hybridization was
prepared by combining 20 µg of fragmented cRNA and
was  hybridized to an Affymetrix HG U133 Plus 2.0 chip.
Chips were washed and stained using the EukGE-WS2v5
protocol on an Affymetrix fluidics 450 station. The stain
included streptavidin-phycoerythrin (10 µg/mL) and
biotinylated goat anti-streptavidin (3 µg/mL). Fluorescence
intensities were captured with an argonion laser confocal
scanner.
Analysis of GeneChip data
Scanned output files were analyzed with GeneChip
Operating Software 1.2 (GCOS; Affymetrix, Santa Clara,
CA, USA). Fluorescence intensity was measured for each
chip and normalized to the average fluorescence intensity
for the entire chip. The normalized data set from three
independent replicates (day 7 post IR; untreated controls
versus irradiated THP-1 cells with a 20 Gy dose) was used
for the Significance Analysis of Microarrays (SAM).26 The
SAM statistic identifies significant changes in gene expres-
sion by performing a set of gene-specific t-tests. A score is
calculated for each gene on the basis of changes in its
expression relative to the standard of repeated measure-
ments for that gene. Genes with scores greater than a
threshold ∆ are defined as significantly deregulated. A false
discovery rate can be estimated from random permutations
of all measurements. A cut-off of 1.8-fold expression (q-
value ≤5%, only for TF gene: q-value >5%) was set to iden-
Table 1A. Primer and Probe Sequences, conditions and perform-
ance (50°C, 2min; 95°C, 10min; 40 cycles 95°C, 15s, 60°C,
1min) of quantitative real-time RT- PCR (QRTPCR) and convention-
al RT- PCR (cDNA standards for real time RT-PCR).
Primer and probe (100 nm) sequences Amplicons (bp)
HTF upper (sea): 5'- GAA GCA GAC GTA CTT GGC ACG G
HTF lower (asb): 5'- CCG AGG TTT GTC TCC AGG TA 126
HTF So2: 5'- FAM-CAG GGA ATG TGG AGA GCA CCG 
GTT CTG T XcT--PH
HGAPDH T
fwd (sea): 5'- CCA CCC ATG GCA AAT TCC                
HGAPDH T
rev 2(asb): 5'- TCG CTC CTG GAA GAT GGT G 250
HGAPDH So: 5'- FAM-TGG CAC CGT CAA GGC TGA GAA CGT XcT--PH
Primer sequences, conditions and performance of conventional RT- PCR
(cDNA standards for real time RT-PCR).
human tissue factor (TF):
initial denaturation: 94°C, 2 min, 94°C, 30 s, 60°C, 30s ; 72°C, 90 s for 30
cycles; final extension: 72°C, 5 min 
human GAPDH:
initial denaturation: 94°C, 2 min, 94°C, 30 s, 58°C, 30s ; 72°C, 90 s for 30
cycles; final extension: 72°C, 5 min 
HTF left1: 5’-CGC CGC CAA CTGGTAGAC 931
HTFright1: 5’-TGC AGT AGC TCC AAC AGT GC
HGAPDH stFOR: 5’-GCC ACA TCG CTC AGA CAC CAT 1229
HGAPDH stREV: 5’-GGT TGA GCA CAG GGT ACT TTA TTG ATG
ase: sense; bas: antisense; cX:TAMRA.
Table 1B. Primers for QRTPCR analysis of expression levels of
selected genes of  IR exposed THP-1 cells.







HGAPDH CCA CCC ATG GCA AAT TCC TCG CTC CTG GAA GAT GGT G
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tify genes whose expression was significantly differentially
regulated. 
Statistical analysis
Data analysis was performed using SPSS 12.0. The
Kolmogorov-Smirnov-Test was performed to test data dis-
tribution. Values are presented as mean ± standard error of
mean (SEM) or median and interquartile range for non-
parametric data. For parametric data, statistical significance
of differences between groups was determined by applying
the unpaired Student t-test or one-way analysis of variance
(ANOVA) for multiple comparisons. The Mann-Whitney
U-test was performed for non-parametric data: p<0.05 was
considered significant. All experiments were performed at
least five times.
Results
IR-induced upregulation of TF mRNA, protein and
procoagulability in human monocytic cells
QRTPCR was performed on irradiated and non-irradiat-
ed THP-1 cells to investigate the effect of IR on TF expres-
sion. IR led to an increased mRNA expression of TF in irra-
diated THP-1 cells (Figure 1). On day 3 post IR (control vs.
20 Gy [p≤0.05] and vs. 40 Gy [p≤0.01]) and on day 7 post
IR, TF/GAPDH mRNA ratios gave the highest mRNA
expression levels (control vs. 20 Gy [p≤0.01] and vs. 40 Gy
[p≤0.01], repectively) indicating a late induction of TF.
PBMNCs were isolated from human peripheral blood to
analyze the TF mRNA expression of mononuclear cells
compared with the THP-1 cell model. A significant
increase in TF/GAPDH mRNA ratios was found 1 day post
IR (0.00041±0.00006 vs. 0.0022±0.0006, baseline vs. 20
Gy, p=0.008) and 3 days post IR of PBMNCs
(0.00041±0.00006 vs. 0.006±0.002, baseline vs. 20 Gy,
p=0.0016).
To analyze the NFκB-pathway related TF expression
post IR, we performed mRNA expression studies by using
the NFκB inhibitor BAY 11-7082. This inhibits IκBα phos-
phorylation. An inhibitor concentration of 5 µM had
almost no effect on the growth of THP-1 cells. A signifi-
cant inhibition of TF mRNA expression in irradiated cells
pretreated with BAY 11-7082 was seen 3 days post IR
compared to irradiated cells cultured without NFκB
inhibitor (ratio HTF/HGAPDH 0.010±0.001 vs.
0.066±0.018; p≤0.0001). At day 3, when THP-1 cells were
pretreated with NFκB inhibitor without application of IR,
the TF mRNA expression of the NFκB inhibitor-pretreated
cells was significantly downregulated compared to
untreated control cells (ratio HTF/HGAPDH 0.009±0.001
vs. 0.012±0.001; p≥0.05). However, the application of IR
without pretreatment with BAY11-7082 was associated
with an increased TF mRNA expression compared to non-
irradiated and untreated control cells 3 days post IR (ratio
HTF/HGAPDH 0.066±0.018 vs. 0.012±0.001; p≤0.001). To
confirm the data obtained on mRNA level, IR-induced
expression of TF protein in THP-1 cells was quantified by
ELISA recognizing human TF. A significant increase in cel-
lular TF protein became prominent 3 days post IR with 20
Gy and with 40 Gy and persisted throughout the period of
study (Figure 2A). A significant increase in cellular TF
activity was already found 1 day post IR with 20 Gy and
with 40 Gy, indicating IR alters cellular thrombogenicity
(Figure 2B). A 12-fold increase was seen 7 days post IR
with a dose of 20 Gy (Figure 2B, p≤0.001) and 40 Gy
(p≤0.001) compared with untreated THP-1 control cells.
Increased cellular prothrombogenicity was persistently
measurable throughout the period of study (day 0-day 17)
(Figure 2B). 
Figure 1. TF mRNA expression in THP-1 cells pre and 1, 3, 7 days
post ionizing radiation (IR) with 0, 20 and 40 Gy. Upregulated TF
mRNA 3 days post IR with doses of 20 and 40 Gy *p ≤0.05 †p
≤0.01 vs. control; ‡p≤0.001 vs. control.
Figure 2. A. TF protein expression pre
and 1, 3, 7, 10 and 17 days post ionizing
radiation (IR) with 0, 20 and 40 Gy.
Ionizing radiation-induced TF protein
synthesis of THP-1 monocytic cells 3
days post IR. *p≤0.05; †p≤0.01 vs. con-
trol. B. TF associated procoagulant activ-
ity pre and 1, 3, 7, 10 and 17 days post
IR. TF procoagulant activity increased 1
day post IR with doses of 0, 20 and 40
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Microarray analysis post IR: altered transcriptional
Tissue Factor and gene expression profiles 
Genechip microarray analysis was performed to clari-
fy possible mechanisms underlying the increased expres-
sion of TF in THP-1 cells post IR. 
The data discussed in this publication have been
deposited in NCBIs Gene Expression Omnibus (GEO,
http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through GEO Series access number GSE4110. We found
a panel of candidate genes to be upregulated on day 3
and day 7 post IR. We performed only one pair of
microarray analysis with day 3 post IR and the untreated
control. On day 3 post IR, a generally weaker expression
pattern of differentially expressed genes in irradiated
THP-1 cells was detected. Therefore, 3 further replicate
pairs (treated vs. untreated state) were chosen for the
SAM statistics (Table 2). The number of genes with ele-
vated expression increased in relation to an increased
duration of culture time post IR. All detected 422 gene
transcripts with known functions and significant upregu-
lation (>1.8-fold, q≤5%) on day 7 post IR compared to
non-irradiated controls are available in the online supple-
ment.  Altered transcription patterns post IR revealed
genes belonging to the following groups: inflamm-
ation/cell defense, cell cycle arrest/apoptosis, regulation
of transcription, nucleic acid metabolism, protein modifi-
cation, cell structure/motility, and signaling/communica-
tion (Table 2). 
IR-responsive gene expression involved in regulation of
cell thrombogenicity
We focussed on genes involved in inflammatory and
apoptotic pathways which are known to be linked to
changes in cellular thrombogenicity (Table 3). To validate
upregulation of these candidate transcripts, SYBR Green
QRTPCR was performed as well as the microarrays
(Table 3). 
The group IV phospholipase A2 (group IVC, cytosolic,
Ca2+-independent; PLA2G4C) gene encodes for an
enzyme important in membrane remodelling, activation
and symmetry of lipid membrane, which is involved in
cell thrombogenicity. QRTPCR confirmed a 4.1-fold
Table 2. Differentially expressed genes in irradiated THP-1 cells.  Data from individual samples for genes arranged in functional group-
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upregulation of the group IV phospholipase A2 gene.
QRTPCR also confirmed upregulation of cathepsin D
(CTSD), an inducer of apoptosis in monocytes (Table 3). 
Since TF is upregulated in monocytes under inflamma-
tory conditions, especially by stimulation with TNF-α,
we further verified the upregulation of TNFRSF10B
(TRAIL R2/APO2LR/Killer/DR5). This is a gene for TNF-
related apoptosis-inducing ligand receptor 2 belonging to
the cell signaling/communication group, known to be
caspase-dependent and associated with apoptotic path-
ways (Table 3). QRTPCR showed IR clearly increased
production of TNF (ligand) superfamily, member 13B
(TNFSF13B) gene, a TNF-and APOL-related leukocyte
expressed ligand 1, which is a TNF homolog activating
the NFκB-, the JNK pathway and inducing apoptosis
(Table 3). IFN-α inducible protein 27 (IFI27) gene was
also seen to be highly upregulated post IR (Table 3). 
We found three genes (TNFRSF10B, TNFSF13B and
IFN-α inducible protein 27) whose regulation according to
QRTPCR was considerably greater. This was also true of
the TF gene, which was 1.8-fold (q-value > 5%) upregu-
lated in the microarray experiment compared to a 3-fold
upregulation measured by SYBR Green QRTPCR. 
Discussion
In the present study IR was found to induce a persist-
ent upregulation of TF on mRNA and protein level as
well as TF procoagulant activity. Gene expression profil-
ing showed IR also upregulated inflammatory and apop-
tosis-related pathways.  TF activity was already upregu-
lated on day 1 post IR, while increased TF protein and
mRNA expression were found on day 3 in PBMNCs and
in THP-1 cells. Although in many tumor cells all func-
tional TF molecules are localized on the outer cell mem-
brane, the procoagulant activity on the intact cell surface
is largely dormant and can be enhanced by cell injury or
damage.27 Bach et al.28 described cellular TF activity to be
encrypted. TF may be deencrypted in several ways, for
example by non-ionic detergents or calcium ionophores,
thus leading to an increased TF activity without increas-
ing TF mRNA or antigen expression. IR-induced activa-
tion of constitutively expressed TF on THP-1 cells may
account for the early increase in procoagulant activity
which was measurable before upregulated TF mRNA
levels were found. As far as the extent of TF upregulation
is concerned, a correlation was seen between the fold
changes in normalized intensities as determined by
microarrays and by QRTPCR analysis (Table 3).
However, the magnitude of gene upregulation measured
by SYBR Green QRTPCR was considerably higher in
some of the candidate genes (Table 3). Compared to
QRTPCR, the probeset for the TF gene on the microarray
was  not as sufficient for hybridization with cRNA of
monocytic THP-1 cells potentially leading to weak signal
intensities and lower ratio. Expression levels detected by
QRTPCR were generally stronger than those obtained by
the cDNA microarray. This fact may explain the
observed differences in gene expression levels as present-
ed here (Table 3). To widen out knowledge of the mech-
anisms and pathways involved in the delayed response
to irradiation, gene expression patterns in irradiated and
non-irradiated THP-1 cells were compared. We found an
upregulation of a phospholipase A2 (PLA2) gene. This is
involved in the assembly of membranes with coordinate
synthesis, catabolism, and transport of phospholipids. In
whole blood, activation of transcription factors is medi-
ated through the phospholipase A2 pathway. At the sur-
face of viable cells, the transmembrane phospholipid dis-
Table 3. Comparison of relative expression levels measured by microarray analysis and by SYBR Green QRTPCR for selected genes.
Fold change Fold change Putative effect on
micro-array control/ 7 days post 
IR (20 Gy)
Gene ID Gene name day 3 day 7 QRT-PCR q-value  [%] Signaling Apoptosis
209785_s_at phospholipase A2 − 3.6 4.1 0.62 − +
(group IVC, cytosolic,
Ca-independent; PLA2G4C
202284_s_at P21/CIP1 2.6 2.6 6.4 1.59 − (-) cell proliferation
227863_at Cathepsin D; CTSD − 2.2 3.9 2.85 − +
209295_¬at TNFRSF10B
(TRAIL R2/Killer/DR5) 2.3 1.8 6.3 4.0 − +
223502_s_at TNFSF13B − 3.5 17.1 0 + −
202411_at IFN-α inducible protein 27; IFI27 2.3 20 166 0 + −
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tribution and its regulation may be important for the
expression of the catalytic activity of the complex of TF
and activated Factor VII.29 Furthermore, phosphatidylser-
ine supports the activity of the cell surface-complex of
TF/FVIIa. Recent studies have shown that phos-
phatidylserine exposure is one of the earliest manifesta-
tions of apoptosis, and that it precedes loss of membrane
integrity.30 Other cell death markers such as cathepsin D
(CTSD) were also found to be increased post IR. 
Several transcripts for interferon-inducible proteins
along with those for IFN-α (IFN-α inducible protein 27;
IFI27) and IFN-γ showed elevated expression levels on
day 3 and on day 7 post IR. IFN-α was reported to
increase TNF-α induced apoptosis and, therefore, mono-
cytes have been shown to rapidly undergo apoptosis in
cultures. By contrast, endogenously produced TNF-α
after γ-irradiation was reported to result in enhanced
monocyte survival by reducing induction of apoptosis.31
Many downstream targets of interferon were gradually
induced following IR treatment. It is known that interfer-
on operates through the JAK-STAT pathway in response
to viral infections to mediate transcriptional changes in
target genes. This results in antiproliferative effects,
involved in suppressing viral replication. In case of IR
stress, interferon activity may promote the same effects
to prevent propagation of DNA damage.32 TNFRSF10B
(TRAILR2) was found to be upregulated post IR. This
TNF-α receptor is a potential activator of the NFκB path-
way.33 It is known that increased expression of the TF
gene resulting in increased procoagulability is regulated
via NFκB by various transcription factors, including
NFκB/Rel proteins and Egr-1.34 Hachiya and co-workers25
ahowed that irradiation increased the NFκB binding
activity and increased the production of TNF-α in THP-1
cells. Endogenous production of TNF-α is known to be
required for NFκB activation post IR.35 Treatment of these
cells with anti-TNF-α antibodies blocked the activation
of NFκB induced by irradiation and exogenously added
TNF-α stimulated NFκB activation. This is in line with
the inhibition of TF mRNA expression in THP-1 cells
using the NFκB pathway inhibitor BAY 11-7082 as
shown here. 
In conclusion, irradiation of human monocytic cells
induced the upregulation of TF expression and proco-
agulant activity. The findings on upregulated TF
mRNA expression in PBMNCs post IR are in line with
our data obtained from irradiated THP-1 cells. We con-
clude that the THP-1 cells are a suitable model for
studying the effect of various agonists on TF expres-
sion levels in human mononuclear cells. The demon-
strated upregulation of TF and other regulatory path-
ways might play a pivotal role in radiation associated
thrombosis and further studies are warranted to inves-
tigate this hypothesis.
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